176 related articles for article (PubMed ID: 16268262)
41. The use of galiximab in non-Hodgkin lymphoma.
Vinjamaram S; Czuczman MS; Hernandez-Ilizaliturri FJ
Clin Lymphoma Myeloma; 2008 Oct; 8(5):277-82. PubMed ID: 18854281
[TBL] [Abstract][Full Text] [Related]
42. Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome.
Coccia P; Mastrangelo S; Ruggiero A; Scalzone M; Rosolen A; Maurizi P; Riccardi R
Pediatr Blood Cancer; 2012 Aug; 59(2):318-9. PubMed ID: 22052860
[TBL] [Abstract][Full Text] [Related]
43. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy.
Martinelli G; Laszlo D; Ferreri AJ; Pruneri G; Ponzoni M; Conconi A; Crosta C; Pedrinis E; Bertoni F; Calabrese L; Zucca E
J Clin Oncol; 2005 Mar; 23(9):1979-83. PubMed ID: 15668468
[TBL] [Abstract][Full Text] [Related]
44. Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.
Aydin S; Dührsen U; Nückel H
Ann Hematol; 2007 Apr; 86(4):271-6. PubMed ID: 17216473
[TBL] [Abstract][Full Text] [Related]
45. Rituximab in high-grade lymphoma.
Zwick C; Murawski N; Pfreundschuh M;
Semin Hematol; 2010 Apr; 47(2):148-55. PubMed ID: 20350662
[TBL] [Abstract][Full Text] [Related]
46. [Clinical trial of the monoclonal antibody drug mabthera (Rituximab) in the treatment of non-Hodgkin lymphoma].
Korolenko VO; Gershanovich ML; Leenman EE; Tikhonova VV
Vopr Onkol; 2003; 49(4):459-63. PubMed ID: 14569937
[TBL] [Abstract][Full Text] [Related]
47. [Monoclonal antibody immunotherapy for malignant non-Hodgkin's lymphoma].
Jourdan E; Richard B
Presse Med; 2000 Apr; 29(13):717-21. PubMed ID: 10797826
[TBL] [Abstract][Full Text] [Related]
48. Treatment of low-grade B-cell lymphoma with the monoclonal antibody rituximab.
Dillman RO
Semin Oncol; 2003 Aug; 30(4):434-47. PubMed ID: 12939712
[TBL] [Abstract][Full Text] [Related]
49. CD20-negative relapse after (131)I-anti-CD20 therapy.
Venugopal P; Leslie WT; O'Brien T; Gregory SA
J Clin Oncol; 1999 Nov; 17(11):3692-3. PubMed ID: 10550173
[No Abstract] [Full Text] [Related]
50. Ten years of rituximab in NHL.
Winter MC; Hancock BW
Expert Opin Drug Saf; 2009 Mar; 8(2):223-35. PubMed ID: 19243307
[TBL] [Abstract][Full Text] [Related]
51. A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections.
Seyfizadeh N; Seyfizadeh N; Hasenkamp J; Huerta-Yepez S
Crit Rev Oncol Hematol; 2016 Jan; 97():275-90. PubMed ID: 26443686
[TBL] [Abstract][Full Text] [Related]
52. [Auto-immune manifestations in Non-Hodgkin's lymphoma].
Jardin F; Lévesque H; Tilly H
Rev Med Interne; 2005 Jul; 26(7):557-71. PubMed ID: 15996570
[TBL] [Abstract][Full Text] [Related]
53. Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.
Hainsworth JD; Burris HA; Morrissey LH; Litchy S; Scullin DC; Bearden JD; Richards P; Greco FA
Blood; 2000 May; 95(10):3052-6. PubMed ID: 10807768
[TBL] [Abstract][Full Text] [Related]
54. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases.
Zompi S; Tulliez M; Conti F; Leblond V; Gaulard P; Blanche P; Durand F; Ghandi D; Dreyfus F; Louvel A; Calmus Y; Bouscary D
J Hepatol; 2000 Mar; 32(3):521-7. PubMed ID: 10735625
[TBL] [Abstract][Full Text] [Related]
55. [New treatment for orbital non-Hodgkin's lymphoma: 2 cases treated with rituximab].
Benabid L; Desablens B; Defossez T; Malthieu D; Milazzo S; Turut P
J Fr Ophtalmol; 2005 Sep; 28(7):769-71. PubMed ID: 16208229
[TBL] [Abstract][Full Text] [Related]
56. Regression of cutaneous intravascular lymphoma with rituximab.
Han K; Haley JC; Carlson K; Pinter-Brown L; Soriano T
Cutis; 2003 Aug; 72(2):137-40. PubMed ID: 12953938
[TBL] [Abstract][Full Text] [Related]
57. Rituximab immunotherapy.
Schilder R
Cancer Biother Radiopharm; 1999 Aug; 14(4):237-40. PubMed ID: 10850309
[TBL] [Abstract][Full Text] [Related]
58. Lymphoid aggregates in bone marrow mimic residual lymphoma after rituximab therapy for non-Hodgkin lymphoma.
Douglas VK; Gordon LI; Goolsby CL; White CA; Peterson LC
Am J Clin Pathol; 1999 Dec; 112(6):844-53. PubMed ID: 10587708
[TBL] [Abstract][Full Text] [Related]
59. Rituximab.
Onrust SV; Lamb HM; Balfour JA
Drugs; 1999 Jul; 58(1):79-88; discussion 89-90. PubMed ID: 10439931
[TBL] [Abstract][Full Text] [Related]
60. Bone marrow remission of hairy cell leukaemia induced by rituximab (anti-CD20 monoclonal antibody) in a patient refractory to cladribine.
Hoffman M; Auerbach L
Br J Haematol; 2000 Jun; 109(4):900-1. PubMed ID: 10970137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
